Literature DB >> 20203524

Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.

Brandon L Pierce1, Habibul Ahsan.   

Abstract

OBJECTIVE: To examine the collective effects of type 1 (T1D) and type 2 diabetes (T2D) risk alleles on prostate cancer (PCa) risk.
METHODS: Using data on 14 and 18 single nucleotide polymorphisms (SNPs) that effect T1D and T2D risk, respectively, we generated risk scores (a 'risk allele count' and a 'genetic relative risk') for both T1D and T2D for 1,171 non-Hispanic white, PSA-screened PCa cases and 1,101 matched controls from the Cancer Genetic Markers of Susceptibility study. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations between the diabetes risk scores and PCa risk.
RESULTS: Both T2D risk scores, but neither T1D score, showed an inverse association with PCa (p < 0.01). These associations remained significant after excluding HNF1B SNP rs4430796 (a known PCa risk factor) from the analysis. The highest quartile of the T2D allele count (>20 risk alleles) was associated with reduced PCa risk (OR = 0.77; CI: 0.60-0.99) compared to the lowest category (<17 risk alleles).
CONCLUSIONS: These results suggest that individuals with increased genetic susceptibility to T2D have decreased risk for PCa. This association is consistent with the observation that individuals with T2D are at decreased risk for PCa; however, data on T2D status was not available for this analysis. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20203524      PMCID: PMC2866577          DOI: 10.1159/000289594

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  40 in total

1.  A meta-analysis of diabetes mellitus and the risk of prostate cancer.

Authors:  Jocelyn S Kasper; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

2.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.

Authors:  Julius Gudmundsson; Patrick Sulem; Valgerdur Steinthorsdottir; Jon T Bergthorsson; Gudmar Thorleifsson; Andrei Manolescu; Thorunn Rafnar; Daniel Gudbjartsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Thorarinn Blondal; Simon N Stacey; Agnar Helgason; Steinunn Gunnarsdottir; Adalheidur Olafsdottir; Kari T Kristinsson; Birgitta Birgisdottir; Shyamali Ghosh; Steinunn Thorlacius; Dana Magnusdottir; Gerdur Stefansdottir; Kristleifur Kristjansson; Yu Bagger; Robert L Wilensky; Muredach P Reilly; Andrew D Morris; Charlotte H Kimber; Adebowale Adeyemo; Yuanxiu Chen; Jie Zhou; Wing-Yee So; Peter C Y Tong; Maggie C Y Ng; Torben Hansen; Gitte Andersen; Knut Borch-Johnsen; Torben Jorgensen; Alejandro Tres; Fernando Fuertes; Manuel Ruiz-Echarri; Laura Asin; Berta Saez; Erica van Boven; Siem Klaver; Dorine W Swinkels; Katja K Aben; Theresa Graif; John Cashy; Brian K Suarez; Onco van Vierssen Trip; Michael L Frigge; Carole Ober; Marten H Hofker; Cisca Wijmenga; Claus Christiansen; Daniel J Rader; Colin N A Palmer; Charles Rotimi; Juliana C N Chan; Oluf Pedersen; Gunnar Sigurdsson; Rafn Benediktsson; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; William J Catalona; Lambertus A Kiemeney; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

3.  A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.

Authors:  Hakon Hakonarson; Struan F A Grant; Jonathan P Bradfield; Luc Marchand; Cecilia E Kim; Joseph T Glessner; Rosemarie Grabs; Tracy Casalunovo; Shayne P Taback; Edward C Frackelton; Margaret L Lawson; Luke J Robinson; Robert Skraban; Yang Lu; Rosetta M Chiavacci; Charles A Stanley; Susan E Kirsch; Eric F Rappaport; Jordan S Orange; Dimitri S Monos; Marcella Devoto; Hui-Qi Qu; Constantin Polychronakos
Journal:  Nature       Date:  2007-07-15       Impact factor: 49.962

4.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

5.  Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

Authors:  David M Werny; Mona Saraiya; Edward W Gregg
Journal:  Am J Epidemiol       Date:  2006-10-05       Impact factor: 4.897

6.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.

Authors:  Meredith Yeager; Nick Orr; Richard B Hayes; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Mark J Minichiello; Paul Fearnhead; Kai Yu; Nilanjan Chatterjee; Zhaoming Wang; Robert Welch; Brian J Staats; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; Edward P Gelmann; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; David J Hunter; Stephen J Chanock; Gilles Thomas
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

Review 7.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

8.  A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

Authors:  Laura J Scott; Karen L Mohlke; Lori L Bonnycastle; Cristen J Willer; Yun Li; William L Duren; Michael R Erdos; Heather M Stringham; Peter S Chines; Anne U Jackson; Ludmila Prokunina-Olsson; Chia-Jen Ding; Amy J Swift; Narisu Narisu; Tianle Hu; Randall Pruim; Rui Xiao; Xiao-Yi Li; Karen N Conneely; Nancy L Riebow; Andrew G Sprau; Maurine Tong; Peggy P White; Kurt N Hetrick; Michael W Barnhart; Craig W Bark; Janet L Goldstein; Lee Watkins; Fang Xiang; Jouko Saramies; Thomas A Buchanan; Richard M Watanabe; Timo T Valle; Leena Kinnunen; Gonçalo R Abecasis; Elizabeth W Pugh; Kimberly F Doheny; Richard N Bergman; Jaakko Tuomilehto; Francis S Collins; Michael Boehnke
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.

Authors:  Valgerdur Steinthorsdottir; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Thorbjorg Jonsdottir; G Bragi Walters; Unnur Styrkarsdottir; Solveig Gretarsdottir; Valur Emilsson; Shyamali Ghosh; Adam Baker; Steinunn Snorradottir; Hjordis Bjarnason; Maggie C Y Ng; Torben Hansen; Yu Bagger; Robert L Wilensky; Muredach P Reilly; Adebowale Adeyemo; Yuanxiu Chen; Jie Zhou; Vilmundur Gudnason; Guanjie Chen; Hanxia Huang; Kerrie Lashley; Ayo Doumatey; Wing-Yee So; Ronald C Y Ma; Gitte Andersen; Knut Borch-Johnsen; Torben Jorgensen; Jana V van Vliet-Ostaptchouk; Marten H Hofker; Cisca Wijmenga; Claus Christiansen; Daniel J Rader; Charles Rotimi; Mark Gurney; Juliana C N Chan; Oluf Pedersen; Gunnar Sigurdsson; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-26       Impact factor: 38.330

10.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.

Authors:  John A Todd; Neil M Walker; Jason D Cooper; Deborah J Smyth; Kate Downes; Vincent Plagnol; Rebecca Bailey; Sergey Nejentsev; Sarah F Field; Felicity Payne; Christopher E Lowe; Jeffrey S Szeszko; Jason P Hafler; Lauren Zeitels; Jennie H M Yang; Adrian Vella; Sarah Nutland; Helen E Stevens; Helen Schuilenburg; Gillian Coleman; Meeta Maisuria; William Meadows; Luc J Smink; Barry Healy; Oliver S Burren; Alex A C Lam; Nigel R Ovington; James Allen; Ellen Adlem; Hin-Tak Leung; Chris Wallace; Joanna M M Howson; Cristian Guja; Constantin Ionescu-Tîrgovişte; Matthew J Simmonds; Joanne M Heward; Stephen C L Gough; David B Dunger; Linda S Wicker; David G Clayton
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

View more
  18 in total

1.  No association of type 2 diabetes risk variants and prostate cancer risk: the multiethnic cohort and PAGE.

Authors:  Kevin M Waters; Lynne R Wilkens; Kristine R Monroe; Daniel O Stram; Laurence N Kolonel; Brian E Henderson; Loïc Le Marchand; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

2.  Pleiotropy and pathway analyses of genetic variants associated with both type 2 diabetes and prostate cancer.

Authors:  L A Raynor; James S Pankow; Laura J Rasmussen-Torvik; Weihong Tang; Anna Prizment; David J Couper
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18

3.  Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.

Authors:  Brandon L Pierce; Melissa A Austin; Habibul Ahsan
Journal:  Cancer Causes Control       Date:  2011-03-29       Impact factor: 2.506

4.  Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

Authors:  X-X He; S M Tu; M-H Lee; S-C J Yeung
Journal:  Ann Oncol       Date:  2011-03-17       Impact factor: 32.976

Review 5.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

6.  Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.

Authors:  Mitchell J Machiela; Sara Lindström; Naomi E Allen; Christopher A Haiman; Demetrius Albanes; Aurelio Barricarte; Sonja I Berndt; H Bas Bueno-de-Mesquita; Stephen Chanock; J Michael Gaziano; Susan M Gapstur; Edward Giovannucci; Brian E Henderson; Eric J Jacobs; Laurence N Kolonel; Vittorio Krogh; Jing Ma; Meir J Stampfer; Victoria L Stevens; Daniel O Stram; Anne Tjønneland; Ruth Travis; Walter C Willett; David J Hunter; Loic Le Marchand; Peter Kraft
Journal:  Am J Epidemiol       Date:  2012-11-28       Impact factor: 4.897

7.  Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.

Authors:  Julia Ciampa; Meredith Yeager; Kevin Jacobs; Michael J Thun; Susan Gapstur; Demetrius Albanes; Jarmo Virtamo; Stephanie J Weinstein; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; David Hunter; Robert Hoover; Gilles Thomas; Stephen Chanock; Chris Holmes; Nilanjan Chatterjee
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

8.  Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China.

Authors:  Pian-Hong Zhang; Zhong-Wen Chen; Duo Lv; Yu-Yang Xu; Wei-Ling Gu; Xu-Hui Zhang; Yuan-Luo Le; Hong-hong Zhu; Yi-Min Zhu
Journal:  BMC Public Health       Date:  2012-07-28       Impact factor: 3.295

9.  Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15).

Authors:  Gijs W D Landman; Jana V van Vliet-Ostaptchouk; Nanne Kleefstra; Kornelis J J van Hateren; Iefke Drion; Klaas H Groenier; Rijk O B Gans; Harold Snieder; Marten H Hofker; Henk J G Bilo
Journal:  Cardiovasc Diabetol       Date:  2012-11-07       Impact factor: 9.951

10.  Circadian gene variants and susceptibility to type 2 diabetes: a pilot study.

Authors:  M Ann Kelly; Simon D Rees; M Zafar I Hydrie; A Samad Shera; Srikanth Bellary; J Paul O'Hare; Sudhesh Kumar; Shahrad Taheri; Abdul Basit; Anthony H Barnett
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.